☰

Ramya K. Vadlapatla, Ph.D. - Publications

Affiliations: 
2014 Pharmaceutical Science University of Missouri - Kansas City, USA 
Area:
Pharmacy, Biochemistry
Tree Info Similar researchers PubMed Report error

29 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Vadlapatla RK, Pal D, Mitra AK. Uptake and Permeability Studies to Delineate the Role of Efflux Transporters. Methods in Molecular Biology (Clifton, N.J.). 1395: 69-74. PMID 26910069 DOI: 10.1007/978-1-4939-3347-1_5  0.619
2015 Khurana V, Vadlapudi AD, Vadlapatla RK, Pal D, Mitra AK. Functional characterization and molecular identification of vitamin C transporter (SVCT2) in human corneal epithelial (HCEC) and retinal pigment epithelial (D407) cells. Current Eye Research. 40: 457-69. PMID 25014399 DOI: 10.3109/02713683.2014.935443  0.785
2015 Mitra A, Renukuntla J, Shah S, Boddu S, Vadlapudi A, Vadlapatla R, Pal D. Functional characterization and expression of folate receptor-α in T47D human breast cancer cells Drug Development and Therapeutics. 6: 52. DOI: 10.4103/2394-6555.162441  0.721
2014 Vadlapatla RK, Vadlapudi AD, Pal D, Mitra AK. Role of membrane transporters and metabolizing enzymes in ocular drug delivery. Current Drug Metabolism. 15: 680-93. PMID 25255873 DOI: 10.2174/1389200215666140926152459  0.79
2014 Vadlapatla RK, Patel M, Paturi DK, Pal D, Mitra AK. Clinically relevant drug-drug interactions between antiretrovirals and antifungals. Expert Opinion On Drug Metabolism & Toxicology. 10: 561-80. PMID 24521092 DOI: 10.1517/17425255.2014.883379  0.753
2014 Kwatra D, Vadlapudi AD, Vadlapatla RK, Khurana V, Pal D, Mitra AK. Binary and ternary combinations of anti-HIV protease inhibitors: effect on gene expression and functional activity of CYP3A4 and efflux transporters. Drug Metabolism and Drug Interactions. 29: 101-10. PMID 24399676 DOI: 10.1515/Dmdi-2013-0056  0.783
2014 Vadlapatla RK, Vadlapudi AD, Pal D, Mukherji M, Mitra AK. Ritonavir inhibits HIF-1α-mediated VEGF expression in retinal pigment epithelial cells in vitro. Eye (London, England). 28: 93-101. PMID 24202050 DOI: 10.1038/Eye.2013.240  0.751
2014 Vadlapudi AD, Cholkar K, Vadlapatla RK, Mitra AK. Aqueous nanomicellar formulation for topical delivery of biotinylated lipid prodrug of acyclovir: formulation development and ocular biocompatibility. Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association For Ocular Pharmacology and Therapeutics. 30: 49-58. PMID 24192229 DOI: 10.1089/Jop.2013.0157  0.73
2014 Vadlapatla RK. Ritonavir: A Powerful Boosting Agent for Overcoming Drug Resistance in Cancer Chemotherapy Journal of Cancer Science & Therapy. 6. DOI: 10.4172/1948-5956.1000307  0.485
2013 Patel M, Mandava NK, Vadlapatla RK, Mitra AK. Recent patents and emerging therapeutics for HIV infections: a focus on protease inhibitors. Pharmaceutical Patent Analyst. 2: 513-38. PMID 24237127 DOI: 10.4155/Ppa.13.33  0.751
2013 Vadlapatla RK, Vadlapudi AD, Pal D, Mitra AK. Mechanisms of drug resistance in cancer chemotherapy: coordinated role and regulation of efflux transporters and metabolizing enzymes. Current Pharmaceutical Design. 19: 7126-40. PMID 23829373 DOI: 10.2174/13816128113199990493  0.792
2013 Vadlapatla RK, Vadlapudi AD, Ponnaluri VK, Pal D, Mukherji M, Mitra AK. Molecular expression and functional activity of efflux and influx transporters in hypoxia induced retinal pigment epithelial cells. International Journal of Pharmaceutics. 454: 444-52. PMID 23827654 DOI: 10.1016/J.Ijpharm.2013.06.044  0.806
2013 Vadlapatla RK, Vadlapudi AD, Mitra AK. Hypoxia-inducible factor-1 (HIF-1): a potential target for intervention in ocular neovascular diseases. Current Drug Targets. 14: 919-35. PMID 23701276 DOI: 10.2174/13894501113149990015  0.739
2013 Vadlapudi AD, Vadlapatla RK, Earla R, Sirimulla S, Bailey JB, Pal D, Mitra AK. Novel biotinylated lipid prodrugs of acyclovir for the treatment of herpetic keratitis (HK): transporter recognition, tissue stability and antiviral activity. Pharmaceutical Research. 30: 2063-76. PMID 23657675 DOI: 10.1007/S11095-013-1059-7  0.769
2013 Vadlapudi AD, Vadlapatla RK, Mitra AK. Update on emerging antivirals for the management of herpes simplex virus infections: a patenting perspective. Recent Patents On Anti-Infective Drug Discovery. 8: 55-67. PMID 23331181 DOI: 10.2174/1574891X11308010011  0.75
2013 Vadlapudi AD, Vadlapatla RK, Pal D, Mitra AK. Biotin uptake by T47D breast cancer cells: functional and molecular evidence of sodium-dependent multivitamin transporter (SMVT). International Journal of Pharmaceutics. 441: 535-43. PMID 23142496 DOI: 10.1016/J.Ijpharm.2012.10.047  0.78
2013 Vavilala DT, Vadlapatla RK, Ponnaluri VKC, Prakash S, Mukherji M. Berberine modulates epigenetics via inhibition of hypoxia-induced histone lysine demethylases expression Drug Development Research. 74: 15-22. DOI: 10.1002/Ddr.21051  0.361
2012 Vadlapudi AD, Vadlapatla RK, Pal D, Mitra AK. Functional and molecular aspects of biotin uptake via SMVT in human corneal epithelial (HCEC) and retinal pigment epithelial (D407) cells. The Aaps Journal. 14: 832-42. PMID 22927035 DOI: 10.1208/S12248-012-9399-5  0.77
2012 Patel M, Vadlapatla RK, Shah S, Mitra AK. Molecular expression and functional activity of sodium dependent multivitamin transporter in human prostate cancer cells. International Journal of Pharmaceutics. 436: 324-31. PMID 22732670 DOI: 10.1016/J.Ijpharm.2012.06.011  0.676
2012 Vadlapudi AD, Vadlapatla RK, Kwatra D, Earla R, Samanta SK, Pal D, Mitra AK. Targeted lipid based drug conjugates: a novel strategy for drug delivery. International Journal of Pharmaceutics. 434: 315-24. PMID 22692074 DOI: 10.1016/J.Ijpharm.2012.05.033  0.781
2012 Patel M, Vadlapatla RK, Pal D, Mitra AK. Molecular and functional characterization of riboflavin specific transport system in rat brain capillary endothelial cells. Brain Research. 1468: 1-10. PMID 22683359 DOI: 10.1016/J.Brainres.2012.05.052  0.671
2012 Kwatra D, Budda B, Vadlapudi AD, Vadlapatla RK, Pal D, Mitra AK. Transfected MDCK cell line with enhanced expression of CYP3A4 and P-glycoprotein as a model to study their role in drug transport and metabolism. Molecular Pharmaceutics. 9: 1877-86. PMID 22676443 DOI: 10.1021/Mp200487H  0.759
2012 Vavilala DT, Ponnaluri VK, Vadlapatla RK, Pal D, Mitra AK, Mukherji M. Honokiol inhibits HIF pathway and hypoxia-induced expression of histone lysine demethylases. Biochemical and Biophysical Research Communications. 422: 369-74. PMID 22580280 DOI: 10.1016/J.Bbrc.2012.04.143  0.533
2012 Vadlapudi AD, Vadlapatla RK, Mitra AK. Sodium dependent multivitamin transporter (SMVT): a potential target for drug delivery. Current Drug Targets. 13: 994-1003. PMID 22420308 DOI: 10.2174/138945012800675650  0.793
2012 Jwala J, Vadlapatla RK, Vadlapudi AD, Boddu SH, Pal D, Mitra AK. Differential expression of folate receptor-alpha, sodium-dependent multivitamin transporter, and amino acid transporter (B (0, +)) in human retinoblastoma (Y-79) and retinal pigment epithelial (ARPE-19) cell lines. Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association For Ocular Pharmacology and Therapeutics. 28: 237-44. PMID 22304562 DOI: 10.1089/Jop.2011.0155  0.747
2012 Vadlapudi AD, Vadlapatla RK, Mitra AK. Current and emerging antivirals for the treatment of cytomegalovirus (CMV) retinitis: an update on recent patents. Recent Patents On Anti-Infective Drug Discovery. 7: 8-18. PMID 22044356 DOI: 10.2174/157489112799829765  0.767
2011 Ponnaluri VK, Vadlapatla RK, Vavilala DT, Pal D, Mitra AK, Mukherji M. Hypoxia induced expression of histone lysine demethylases: implications in oxygen-dependent retinal neovascular diseases. Biochemical and Biophysical Research Communications. 415: 373-7. PMID 22037463 DOI: 10.1016/J.Bbrc.2011.10.075  0.513
2011 Vadlapatla RK, Vadlapudi AD, Kwatra D, Pal D, Mitra AK. Differential effect of P-gp and MRP2 on cellular translocation of gemifloxacin. International Journal of Pharmaceutics. 420: 26-33. PMID 21864659 DOI: 10.1016/J.Ijpharm.2011.08.009  0.794
2010 Kwatra D, Vadlapatla RK, Vadlapudi AD, Pal D, Mitra AK. Interaction of gatifloxacin with efflux transporters: a possible mechanism for drug resistance. International Journal of Pharmaceutics. 395: 114-21. PMID 20573570 DOI: 10.1016/J.Ijpharm.2010.05.027  0.795
Show low-probability matches.